GlassScriptPhysician profile
Kara J Shirley
NPI 1851687818
$8,456.80
in general payments reported to CMS, 2019-2025
24 companies · $1,536 in 2025
The $1,536 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $351 · 2021: $545 · 2022: $1,474 · 2023: $2,646 · 2024: $1,370 · 2025: $1,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,016 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,016.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,934.03 | 2019-2025 | Precision 1, Dailies Total1, Air Optix Color |
| Bausch & Lomb Americas INC. | $1,178.01 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $508.28 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $502.33 | 2019-2025 | |
| Oyster Point Pharma, INC. | $465.45 | 2022-2025 | Tyrvaya, Ryzumvi |
| Coopervision INC. | $415.74 | 2019-2025 | Clariti Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $311.98 | 2019-2025 | Cequa |
| Biotissue Holdings INC. | $135.14 | 2019-2025 | |
| Lkc Technologies, INC. | $127.64 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $126.45 | 2021-2022 | |
| Abbvie INC. | $124.06 | 2022-2024 | Alphagan P, Lumigan, Vuity |
| Glaukos Corporation | $112.88 | 2022 | |
| Allergan, INC. | $107.83 | 2019-2022 | |
| Dompe US, INC. | $78.87 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $57.00 | 2024-2025 | Xdemvy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $54.32 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $52.83 | 2021 | |
| Thea Pharma INC. | $42.28 | 2024-2025 | Iyuzeh |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Harrow Eye, LLC | $20.01 | 2024 | Vevye |
| Lombart Brothers, INC. | $18.46 | 2021 | |
| Shire North American Group INC | $18.22 | 2019 | |
| Maculogix, INC. | $13.60 | 2020 | |
| Abb Con-Cise Optical Group LLC | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Shirley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.